# TP0502-Pharmaco-Scintigraphic-Study and Amendment

> **NCT02306785** · PHASE1 · COMPLETED · sponsor: **Tillotts Pharma AG** · enrollment: 26 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** TP05 Coating D
- **DRUG:** TP05 Coating E
- **DRUG:** TP05 Coating H

## Key facts

- **NCT ID:** NCT02306785
- **Lead sponsor:** Tillotts Pharma AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-02
- **Final completion:** 2013-06
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02306785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02306785, "TP0502-Pharmaco-Scintigraphic-Study and Amendment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02306785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*